Tags

Type your tag names separated by a space and hit enter

Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Int J Pharm. 2009 Feb 09; 367(1-2):109-14.IJ

Abstract

The purpose of this work was to explore the feasibility of preparing itraconazole hydrochloride to improve the solubility and dissolution rate. Itraconazole dihydrochloride was synthesized by bubbling anhydrous hydrogen chloride gas into the acetone suspension of itraconazole. Results of the elementary analysis gave the molecular formula of C(35)H(38)Cl(2)N(8)O(4).2HCl and its structure was confirmed by Fourier transform infrared (FTIR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Powder X-Ray diffraction (PXRD) suggested that a new crystalline form of the salt was formed. The morphology and mean size distribution study by scanning electron microscopy (SEM) and dynamic light scattering (DLS) confirmed that the salt was dispersable nanoparticle aggregation. Aqueous solubility measurements showed that the solubility of the salt, its 1:1, 1:2 and 1:3 (w/w) physical mixtures with beta-cyclodextrin (beta-CD) was 6, 99, 236 and 388 times greater than itraconazole. More than 94% of itraconazole was dissolved out of the salt/beta-CD 1/3 physical mixture after 60min. The stability studies indicated that the physical mixture remained stable for 24 months in assay, the related substances and dissolution. Based on the present results, it is concluded that hydrochloride formation can significantly increase solubility and dissolution rate of itraconazole, and the formulation of itraconazole dihydrochloride/beta-CD (1/3) would be an environment-friendly, economic and practical alternative to the commercially available itraconazole capsules (Sporanox)

Authors+Show Affiliations

Department of Pharmaceutics, Shanghai Institute of Pharmaceutical Industry, 1111 Zhongshanbeiyi Road, Shanghai, PR China. taotaosipi@hotmail.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18930795

Citation

Tao, Tao, et al. "Preparation and Evaluation of Itraconazole Dihydrochloride for the Solubility and Dissolution Rate Enhancement." International Journal of Pharmaceutics, vol. 367, no. 1-2, 2009, pp. 109-14.
Tao T, Zhao Y, Wu J, et al. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Int J Pharm. 2009;367(1-2):109-14.
Tao, T., Zhao, Y., Wu, J., & Zhou, B. (2009). Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. International Journal of Pharmaceutics, 367(1-2), 109-14. https://doi.org/10.1016/j.ijpharm.2008.09.034
Tao T, et al. Preparation and Evaluation of Itraconazole Dihydrochloride for the Solubility and Dissolution Rate Enhancement. Int J Pharm. 2009 Feb 9;367(1-2):109-14. PubMed PMID: 18930795.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. AU - Tao,Tao, AU - Zhao,Yan, AU - Wu,Jinjin, AU - Zhou,Beiyi, Y1 - 2008/09/30/ PY - 2008/06/13/received PY - 2008/08/02/revised PY - 2008/09/19/accepted PY - 2008/10/22/pubmed PY - 2009/8/12/medline PY - 2008/10/22/entrez SP - 109 EP - 14 JF - International journal of pharmaceutics JO - Int J Pharm VL - 367 IS - 1-2 N2 - The purpose of this work was to explore the feasibility of preparing itraconazole hydrochloride to improve the solubility and dissolution rate. Itraconazole dihydrochloride was synthesized by bubbling anhydrous hydrogen chloride gas into the acetone suspension of itraconazole. Results of the elementary analysis gave the molecular formula of C(35)H(38)Cl(2)N(8)O(4).2HCl and its structure was confirmed by Fourier transform infrared (FTIR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Powder X-Ray diffraction (PXRD) suggested that a new crystalline form of the salt was formed. The morphology and mean size distribution study by scanning electron microscopy (SEM) and dynamic light scattering (DLS) confirmed that the salt was dispersable nanoparticle aggregation. Aqueous solubility measurements showed that the solubility of the salt, its 1:1, 1:2 and 1:3 (w/w) physical mixtures with beta-cyclodextrin (beta-CD) was 6, 99, 236 and 388 times greater than itraconazole. More than 94% of itraconazole was dissolved out of the salt/beta-CD 1/3 physical mixture after 60min. The stability studies indicated that the physical mixture remained stable for 24 months in assay, the related substances and dissolution. Based on the present results, it is concluded that hydrochloride formation can significantly increase solubility and dissolution rate of itraconazole, and the formulation of itraconazole dihydrochloride/beta-CD (1/3) would be an environment-friendly, economic and practical alternative to the commercially available itraconazole capsules (Sporanox) SN - 1873-3476 UR - https://www.unboundmedicine.com/medline/citation/18930795/Preparation_and_evaluation_of_itraconazole_dihydrochloride_for_the_solubility_and_dissolution_rate_enhancement_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5173(08)00664-9 DB - PRIME DP - Unbound Medicine ER -